Alnylam Pharmaceuticals, Inc. (ALNY) stock
ALNYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3047% below fair value
$149.40−7.10 (-4.54%)
Close on Nov 18, 2026Market cap $20.01BP/E 7.8Yield –
Alnylam Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Alnylam Pharmaceuticals's market cap was $21.38B on Nov 11, 2026, against $59.47B a year earlier. Over the last 5 years it ranged from $15.19B to $59.73B, with a median of $27.43B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $21.38B | -59.2% |
| 2025 | Dec 31, 2025 | $52.41B | +72.9% |
| 2024 | Dec 31, 2024 | $30.32B | +26.3% |
| 2023 | Dec 29, 2023 | $24.01B | -17.8% |
| 2022 | Dec 30, 2022 | $29.23B | +44.3% |
| 2021 | Dec 31, 2021 | $20.26B | +34.2% |
| 2020 | Dec 31, 2020 | $15.10B | +17.7% |
| 2019 | Dec 31, 2019 | $12.82B | +74.2% |
| 2018 | Dec 31, 2018 | $7.36B | -37.3% |
| 2017 | Dec 29, 2017 | $11.74B | +265.5% |
| 2016 | Dec 30, 2016 | $3.21B | -59.7% |
| 2015 | Dec 31, 2015 | $7.97B | +7.2% |
| 2014 | Dec 31, 2014 | $7.44B | +82.9% |
| 2013 | Dec 31, 2013 | $4.07B | +325.4% |
| 2012 | Dec 31, 2012 | $955.91M | +174.8% |
| 2011 | Dec 30, 2011 | $347.91M | -16.3% |
| 2010 | Dec 31, 2010 | $415.70M | – |
See a number that looks wrong?